Ensuring Optimal Management of Antibiotic-Resistant Hospital- and Ventilator-Acquired Pneumonia

Target Audience

Infectious disease physicians, infectious disease pharmacists, critical care specialists, pharmacy/formulary directors, and other providers who treat and/or monitor patients with hospital- or ventilator-acquired pneumonias (eg, clinical pharmacists, clinical microbiologists, hospitalists)

Learning Objectives

After completing this activity, participants should be better able to:

• Review the diagnostic approach and pathophysiology of hospital- and ventilator-acquired bacterial pneumonia.
• Describe the health and economic burden of hospital- and ventilator-acquired pneumonia.
• Explain the major mechanisms of resistance seen in nosocomial pneumonias.
• Develop an optimal treatment plan incorporating novel therapies for patients with hospital- or ventilator-acquired bacterial pneumonia including those with antibiotic resistance.